BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 22815155)

  • 1. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
    Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
    Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic iASPP expression as a novel prognostic indicator in oral cavity squamous cell carcinoma.
    Kim JW; Roh JL; Park Y; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Feb; 22(2):662-9. PubMed ID: 25149434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of iASPP correlates with poor prognosis and chemoresistance/radioresistance in FIGO Ib1-IIa squamous cell cervical cancer.
    Cao L; Huang Q; He J; Lu J; Xiong Y
    Cell Tissue Res; 2013 May; 352(2):361-9. PubMed ID: 23420450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LTBP2 is a prognostic marker in head and neck squamous cell carcinoma.
    Han L; Tang MM; Xu X; Jiang B; Huang J; Feng X; Qiang J
    Oncotarget; 2016 Jul; 7(29):45052-45059. PubMed ID: 27281608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low cytoplasmic and nuclear KPNA2 expression in radiotherapy-treated head and neck squamous cell cancer is associated with an adverse outcome.
    Erben PB; Brunner K; Hecht M; Haderlein M; Büttner-Herold M; Agaimy A; Fietkau R; Hartmann A; Distel LV
    Int J Clin Exp Pathol; 2015; 8(12):15814-24. PubMed ID: 26884852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
    Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas.
    García-Carracedo D; Villaronga MÁ; Álvarez-Teijeiro S; Hermida-Prado F; Santamaría I; Allonca E; Suárez-Fernández L; Gonzalez MV; Balbín M; Astudillo A; Martínez-Camblor P; Su GH; Rodrigo JP; García-Pedrero JM
    Oncotarget; 2016 May; 7(20):29780-93. PubMed ID: 27119232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
    Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
    Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).
    Pectasides E; Rampias T; Sasaki C; Perisanidis C; Kouloulias V; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
    PLoS One; 2014; 9(4):e94273. PubMed ID: 24722213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance.
    Wang S; Li S; Yang X; Yang S; Liu S; Liu B; Liu J
    Eur J Cancer; 2014 Jan; 50(2):379-87. PubMed ID: 24189000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of iASPP Expression Suppresses Proliferation, Invasion and Increases Chemosensitivity to Paclitaxel of Head and Neck Squamous Cell Carcinoma
    Liu ZZ; Kuang WL; Zeng WJ; Xiao JY; Tian YQ
    Chin Med Sci J; 2019 Sep; 34(3):184-193. PubMed ID: 31601301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of leucine zipper-EF-hand containing transmembrane protein 1 predicts poor prognosis in head and neck squamous cell carcinoma.
    Chen L; Yang Y; Liu S; Piao L; Zhang Y; Lin Z; Li Z
    Biomed Res Int; 2014; 2014():850316. PubMed ID: 24689060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
    Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
    Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
    J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
    Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
    Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patients.
    Wicker CA; Takiar V; Suganya R; Arnold SM; Brill YM; Chen L; Horbinski CM; Napier D; Valentino J; Kudrimoti MR; Yu G; Izumi T
    Oral Oncol; 2020 Dec; 111():104949. PubMed ID: 32801084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 variant isoforms in head and neck squamous cell carcinoma progression.
    Wang SJ; Wong G; de Heer AM; Xia W; Bourguignon LY
    Laryngoscope; 2009 Aug; 119(8):1518-30. PubMed ID: 19507218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short report.
    Kadletz L; Heiduschka G; Wiebringhaus R; Gurnhofer E; Kotowski U; Haymerle G; Brunner M; Barry C; Kenner L
    Cell Oncol (Dordr); 2017 Apr; 40(2):193-198. PubMed ID: 28039609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of the putative tumor suppressor protein spinophilin is associated with poor prognosis in head and neck cancer.
    Aigelsreiter AM; Aigelsreiter A; Wehrschuetz M; Ress AL; Koller K; Salzwimmer M; Gerger A; Schauer S; Bauernhofer T; Pichler M
    Hum Pathol; 2014 Apr; 45(4):683-90. PubMed ID: 24565202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma differentiation-associated gene-7/interleukin-24 as a potential prognostic biomarker and second primary malignancy indicator in head and neck squamous cell carcinoma patients.
    Wang L; Feng Z; Wu H; Zhang S; Pu Y; Bian H; Wang Y; Guo C
    Tumour Biol; 2014 Nov; 35(11):10977-85. PubMed ID: 25091574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.